September 2019 | 5th Issue
Advance Registration Opens on Sep 23
    In this Issue

Advance Registration Opens on Sep 23
Scientific Program Highlights
Introduction to Local Host

    Advance Registration Opens on Sep 23
Advance registration rates for the 13th APVRS Congress in Shanghai, China are now in effect through November 10, 2019 (Sunday). For more information, please visit our Congress website at http://2019.apvrs.org/registration/. 

For registration of more than 5 delegates, please complete and return the group registration form to the APVRS secretariat at registration@apvrs.org by the above deadline as well.

    Scientific Program Highlights

Diabetic Retinopathy (DR)

  • Treatment: The treatment options for various manifestations of DR have changed dramatically over the last decade with the advent of new imaging, medical, and surgical techniques. This symposium will highlight recent clinically relevant advances in the management of diabetic macular edema and proliferative DR, including specific challenges of non-clearing vitreous hemorrhage, traction retinal detachment, and management during pregnancy, using both didactic and case presentations.

  • Epidemiology, Screening, and Prevention: This session will cover major developments in epidemiology, risk factors and screening for DR, including updates and examples of national screening programs in different countries in Asia. DR screening by fundus photography, usually within a tele-ophthalmology framework, and use of artificial intelligence (AI) algorithms will be also presented. The symposium will cover progress made and challenges that remain in our continuing battle with DR.

Age-related Macular Degeneration (AMD)

  • In this symposium, speakers from around the world will present on the latest development in the pathogenesis and treatment of neovascular AMD, including new pharmacologic agents, long-term result of the IVAN study, gut metagenome and recent advances in imaging of AMD.

The Impact of Systemic Medications on Retinal Function

  • This symposium will provide a thorough review of systemic medications that are capable of causing various patterns of retinal toxicity. Included will be medications that disrupt the retinal pigment epithelium or cause retinal vascular occlusion, cystoid macular edema/retinal edema, crystalline deposition, uveitis and miscellaneous subjective visual symptoms. The mechanism of action will be discussed when known, along with prevention and treatment. Newer entities, such as pentosane, MEK inhibitors and checkpoint inhibitors, will also be explored.

Pediatric Retina: Treatment                   

  • Led by the highly experienced international faculty, this symposium will explore the latest management approaches for a range of pediatric vitreoretinal conditions, including ROP, FEVR, giant retinal tear related retinal detachment and optic disc anomalies. The topical area of neuro-development in ROP following anti-VEGF treatment will also be discussed.

    Introduction to Local Host

The Asia-Pacific Vitreo-retina Society (APVRS) is pleased to join hand with the Chinese Vitreo-retina Society (CVRS) to co-host the 13th APVRS Congress cum Retina China 2020. Big thanks to CVRS for their support.

Consisting of more than 5,000 vitreo-retinal specialists, CVRS provides an excellent platform for idea exchange, new information sharing, as well as skills and knowledge integration of ophthalmologists in the vitreo-retinal field. Its annual meeting, Retina China, is one of the most important ophthalmological conferences in China. More than 4000 participants from China and overseas gather to share the latest breakthroughs in vision research, exchange innovative scientific ideas and present interesting clinical cases.


APVRS Secretariat


Phone: (852) 3943-5889
Fax: (852) 2715-9490
Email: secretariat@apvrs.org 
Website: http://2019.apvrs.org/

Want to change how you receive these emails?
You can
update your preferences or unsubscribe from this list .